Kenneth Hoberman
Chief Operating Officer at STEMLINE THERAPEUTICS, INC.
Net worth: 4 M $ as of 29/04/2024
Network origin in Kenneth Hoberman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 19 | |
| Subsidiary | Pharmaceuticals: Major | 17 | |
| Public Company | Pharmaceuticals: Major | 13 | |
| Public Company | Pharmaceuticals: Major | 7 | |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY.
5
| Holding Company | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kenneth Hoberman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
| CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Pharmaceuticals: Other | Chief Executive Officer President Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder Public Communications Contact Director of Finance/CFO | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Siena College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Masters Business Admin Graduate Degree | |
| NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Chairman Director/Board Member Director/Board Member | |
| MUSTANG BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| New York University | College/University | Undergraduate Degree Masters Business Admin | |
| Baruch College | College/University | Undergraduate Degree Undergraduate Degree | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| PURPLE BIOTECH LTD | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| Robert H. Smith School of Business | College/University | Undergraduate Degree Masters Business Admin | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| ACADIA REALTY TRUST | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
| Fairleigh Dickinson University | College/University | Masters Business Admin Undergraduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| MESOBLAST LIMITED | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Icahn School of Medicine at Mount Sinai | College/University | Corporate Officer/Principal Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Bar-Ilan University | College/University | Masters Business Admin Graduate Degree | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
| JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member | |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AXSOME THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer Director of Finance/CFO | |
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| Cellvation, Inc. | Chairman Director/Board Member | ||
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| DYADIC INTERNATIONAL, INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| UNIQURE N.V. | Biotechnology | Director/Board Member Director/Board Member | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Marvel Entertainment LLC
 Marvel Entertainment LLC Movies/EntertainmentConsumer Services Marvel Entertainment, Inc. engages in publishing and film production services. The firm operates in the licensing, publishing, and film production segments. It produces comics, books, films, animated movies, and television programs. The company was founded in 1988 and is headquartered in New York, NY. | Movies/Entertainment | Director/Board Member | |
| PACIFIC DRILLING S.A. | Contract Drilling | Director/Board Member |
Statistics
International
| United States | 44 |
| Israel | 5 |
| Australia | 2 |
| Netherlands | 2 |
| Luxembourg | 2 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 18 |
| Finance | 6 |
| Commercial Services | 6 |
| Health Services | 2 |
Operational
| Director/Board Member | 210 |
| Corporate Officer/Principal | 105 |
| Independent Dir/Board Member | 81 |
| Director of Finance/CFO | 49 |
| Chairman | 48 |
Most connected contacts
| Insiders | |
|---|---|
| Eric Rowinsky | 36 |
| Uri Ben-Or | 31 |
| J. Buchi | 26 |
| Michael Weiss | 25 |
| Ronald Renaud | 24 |
| Joseph Feczko | 23 |
| Lindsay Rosenwald | 23 |
| Neil Herskowitz | 22 |
| Eric Rose | 21 |
| Kevin Cameron | 17 |
| Laurence Charney | 16 |
| Wyche Fowler | 15 |
| Darren Cline | 15 |
| Eric Dobmeier | 14 |
| Daniel Hume | 14 |
- Stock Market
- Insiders
- Kenneth Hoberman
- Company connections
